MyAverix Finance
BE · Other
ZEALAND PHARMA (22Z)
Other
ZEALAND PHARMA (22Z) is listed on BE in the Other sector. As of 2026-05-24, reported market cap is $775.23M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 22Z
ZEALAND PHARMA (22Z) — FAQ
What is ZEALAND PHARMA's market cap?
ZEALAND PHARMA (22Z) has a reported market cap of $775.23M (data as of 2026-05-24).
What is 22Z's P/E ratio?
The price-to-earnings (P/E) ratio for ZEALAND PHARMA (22Z) is 18.00 (data as of 2026-05-24).
Does ZEALAND PHARMA pay a dividend?
Dividend yield is not available in the current snapshot for ZEALAND PHARMA (22Z). Check the MyAverix Finance app for the latest dividend data.
What sector is ZEALAND PHARMA in?
ZEALAND PHARMA (22Z) is classified in the Other sector.
What exchange is 22Z listed on?
22Z is listed on BE.
What is ZEALAND PHARMA's net margin?
ZEALAND PHARMA (22Z) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.